Toxicity reduction and MMP-2 stimulation of papain and bromelain loaded in elastic niosomes

Journal of Biomedical Nanotechnology

Volumn 8, Issue 5, 2012, Pages 720-729

  Manosroi, Aranya ^a   Chankhampan, Charinya ^a   Manosroi, Worapaka ^b   Manosroi, Jiradej ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Bromelain; Cytotoxicity; Elastic niosomes; MMP 2 stimulation; Papain; Physico chemical stability

Indexed keywords

BROMELAIN; MMP-2 STIMULATION; NIOSOMES; PAPAIN; PHYSICO-CHEMICAL STABILITY;

CELL CULTURE; CYTOTOXICITY; TOXICITY; ZETA POTENTIAL;

ENZYMES;

BROMELAIN; CHOLESTEROL; CHOLIC ACID; GELATINASE A; NIOSOME; PAPAIN;

ARTICLE; ASSAY; CYTOTOXICITY; ELASTICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NONHUMAN; PHYSICAL CHEMISTRY; SCAR; SKIN FIBROBLAST; TEMPERATURE; ZETA POTENTIAL; ZYMOGRAPHY;

BROMELAINS; CELL SURVIVAL; CELLS, CULTURED; ELASTIC MODULUS; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 2; NANOCAPSULES; PAPAIN;

EID: 84865108558     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1458     Document Type: Article

References (40)

1. S. Afaq and J. Iqbal, Immobilization and stabilization of papain on chelating sepharose: A metal chelate regenerable carrier. Electron J. Biotechnol. 3, 1 (2001).
2. L. P. Hale, P. K. Greer, C. T. Trinh, and C. L. James, Proteinase activity and stability of natural bromelain preparations. Int. Immunopharmacol. 5, 783-793 (2005).
3. E. P. S. Ceniceros, A. Ilyina, J. C. C. Esquivel, D. R. Menchaca, J. C. F. Espinoza, and O. E. M. Rodriguez, Entrapment of enzymes in natural polymeer extracted from residue of food industry: Preparation methods, partial characterisation and possible application. BECTH. MOCK. 44, 84 (2003).
4. M. G. Sankalia, R. C. Mashru, J. M. Sankalia, and V. B. Sutariya, Physicochemical characterization of papain entrapped in ionotropically cross-linked kappa-carrageenan gel beads for stability improvement using Doehlert shell design. J. Pharm. Sci. 95, 19994 (2006).
5. S. S. Poh and F. A. A. Majid, Thermal stability of free bromelain and bromelain-polyphenol complex in pineapple juice. Int. Food Res. J. 18, 1051 (2011).
6. A. Manosroi, P. Jantrawut, T. Akihisa, W. Manosroi, and J. Manosroi, In vitro anti-aging activities of Terminalia chebula gall extract. Pharm. Biol. 48, 469 (2010).
7. N. Z. I. Roslan, A. A. Aziz, M. R. Sarmidi, and R. A. Azizb, Antioxidant coated liposome as the delivery system for papain based natural cosmetics, Proceeding of International Conference on Enabling Science and Nanotechnology (ESciNano), Kuala Lumpur, Malaysia, December (2010).
8. Y. L. Tan, C. G. Liu, L. J. Yu, and X. G. Chen, Effect of linoleic-acid modified carboxymethyl chitosan on bromelain immobilization onto self-assembled nanoparticles. Front Mater. Sci. China 2, 209 (2008).
9. J. M. López-Pinto, M. L. González-Rodríguez, and A. M. Rabasco, Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int. J. Pharm. 298, 1 (2005).
10. C. Hofer, R. Hartung, R. Göbel, P. Deering, A. Lehmer, and J. Breul, New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-α: Theoretic and practical aspects. World J. Surg. 24, 1187 (2000).
11. I. J. Ayogu, O. Ogbonna, C. I. Ayolugbe, and A. A. Attama, Evaluation of the pharmacodynamic activity of insulin from bilosomal formulation, Current Drug Delivery 6, 415 (2009).
12. A. Manosroi, C. Chankhampan, H. Ofoghi, W. Manosroi, and J. Manosroi, Low cytotoxic elastic niosomes loaded with salmon calcitonin on human skin fibroblasts. Hum. Exp. Toxicol. (2012), In press.
13. A. Manosroi, P. Jantrawut, and J. Manosroi, Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int. J. Pharm. 360, 156 (2008).
14. S. Jain, A. K. Tiwary, B. Sapra, and N. K. Jain, Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm. Sci. Tech. 8, E1 (2007).
15. B. A. I. Bergh, P. W. Wertz, H. E. Junginger, and J. A. Bouwstra, Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements, Int. J. Pharm. 217, 13 (2001).
16. V. D. Wagh and O. J. Deshmukh, Niosomes as ophthalmic drug delivery systems: A review. J. Pharm. Res. 3, 1558 (2010).
17. K. T. Papazisis, G. D. Geromichalos, K. A. Dimitriadis, and A. H. Kortsaris, Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods 208, 151 (1997).
18. W. Bouquet, T. Boterberg, W. Ceelen, P. Pattyn, M. Peeters, M. Bracke, J. P. Remon, and C. Vervaet, In vitro cytotoxicity of paclitaxel/[beta]- cyclodextrin complexes for HIPEC. Int. J. Pharm. 367, 148 (2009).
19. Y. Han, H. Tian, P. He, X. Chen, and X. Jing, Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. Int. J. Pharm. 378, 159 (2009).
20. T. Kobayashi, S. Hattori, and H. Shinkai, Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts, Acta Derm. Venereol. 83, 105 (2003).
21. J. N. Balitaan, H. Steinbrenner, and M. C. Ramos, Zymography-based assay for screening potential anti-gelatinase agents using Serratia marcescens, serralysin. Philipp. Sci. Lett. 3, 100 (2010).
22. S. Kim, Y. Kim, J. E. Kim, K. H. Cho, and J. H. Chung, Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15, 340 (2008).
23. P. Carmeliet, L. Moons, J. M. Herbert, J. Crawley, F. Lupu, R. Lijnen, and D. Collen, Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice, Circ. Res. 81, 829 (1997).
24. J. Liu, T. Gong, C. Wang, Z. Zhong, and Z. Zhang, Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int. J. Pharm. 340, 153 (2007).
25. D. Pozzi, R. Caminiti, C. Marianecci, M. Carafa, E. Santucci, S. C. D. Sanctis, and G. Caracciolo, Effect of cholesterol on the formation and hydration behavior of solid-supported niosomal membranes. Langmuir 26, 2268 (2009).
26. G. M. M. E. Maghraby, A. C. Williams, and B. W. Barry, Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 196, 63 (2000).
27. L. Peltonen, P. Koistinen, M. Karjalainen, A. Hakkinen, and J. Hirvonen, The effect of cosolvents on the formulation of nanoparticles from low-molecular-weight poly(l)lactide. AAPS Pharm. Sci. Tech. 3, E32 (2002).
28. A. Manosroi, P. Khanrin, R. G. Werner, F. Gotz, W. Manosroi, and J. Manosroi, Entrapment enhancement of peptide drugs in niosomes, J. Microencapsul. 27, 272 (2010).
29. M. Gulatia, M. Grover, S. Singh, and M. Singh, Lipophilic drug derivatives in liposomes. Int. J. Pharm. 165, 129 (1998).
30. M. Carafa, E. Santucci, and G. Lucania, Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int. J. Pharm. 231, 21 (2002).
31. M. Carafa, C. Marianecci, G. Lucania, E. Marchei, and E. Santucci, New vesicular ampicillin-loaded delivery systems for topical application: Characterization, in vitro permeation experiments and antimicrobial activity. J. Control. Release 95, 67 (2004).
32. I. F. Uchegbu and S. P. Vyas, Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 172, 33 (1998).
33. F. Hashim, M. El-Ridy, M. Nasr, and Y. Abdallah, Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug Deliv. 17, 282 (2010).
34. P. S. Lopes, G. W. Ruas, A. R. Baby, C. A. Sales, D. O. Pinto, I. S. Watanabe, M. V. R. Velasco, and T. M. Kaneko, In vitro safety assessment of papain on human skin: A qualitative light and transmission electron microscopy (TEM) study. Braz. J. Pharm. Sci. 44, 151 (2008).
35. K. Honda, K. Okamoto, Y. Mochida, K. Ishioka, M. Oka, K. Maesato, R. Ikee, H. Moriya, S. Hidaka, T. Ohtake, K. Doi, T. Fujita, S. Kobayashi, and E. Noiri, A novel mechanism in maggot debridement therapy: Protease in excretion/secretion promotes hepatocyte growth factor production. Am. J. Physiol. Cell Physiol. 301, C1423 (2011).
36. J. J. Moreno, Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures. Toxicology 143, 275 (2000).
37. H. Lin, M. Gebhardt, S. Bian, K. A. Kwon, C. K. Shim, S. J. Chung, and D. D. Kima, Enhancing effect of surfactants on fexofenadine • HCl transport across the human nasal epithelial cell monolayer. Int. J. Pharm. 330, 23 (2007).
38. A. Manosroi, P. Khanrin, W. Lohcharoenkal, R. G. Werner, F. Götz, W. Manosroi, and J. Manosroi, Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int. J. Pharm. 392, 304 (2010).
39. Z. Werb, J. Aggeler, Proteases induce secretion of collagenase and plasminogen activator by fibroblasts, Proc. Nati. Acad. Sci. 75, 1839 (1978).
40. J. Y. Kim, J. K. Kim, J. S. Park, Y. Byun, and C. K. Kim, The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 30, 5751 (2009).